NO20042785L - Anvendelse av 2-hydroksy- eller 2-acetyloksy-4-trifluormetylbenzosyrederivater som et middel for behandlingen og forebyggingen av mild kognitiv svekkelse - Google Patents

Anvendelse av 2-hydroksy- eller 2-acetyloksy-4-trifluormetylbenzosyrederivater som et middel for behandlingen og forebyggingen av mild kognitiv svekkelse

Info

Publication number
NO20042785L
NO20042785L NO20042785A NO20042785A NO20042785L NO 20042785 L NO20042785 L NO 20042785L NO 20042785 A NO20042785 A NO 20042785A NO 20042785 A NO20042785 A NO 20042785A NO 20042785 L NO20042785 L NO 20042785L
Authority
NO
Norway
Prior art keywords
acetyloxy
hydroxy
treating
acid derivatives
cognitive impairment
Prior art date
Application number
NO20042785A
Other languages
English (en)
Norwegian (no)
Inventor
Julian Garcia-Rafanell
Genis Munoz Orti
Jose Carlos Navas Ramirez
Jose Ignacio Lzquierdo Pulido
Original Assignee
Uriach Y Compania Sa J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uriach Y Compania Sa J filed Critical Uriach Y Compania Sa J
Publication of NO20042785L publication Critical patent/NO20042785L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20042785A 2001-12-07 2004-07-01 Anvendelse av 2-hydroksy- eller 2-acetyloksy-4-trifluormetylbenzosyrederivater som et middel for behandlingen og forebyggingen av mild kognitiv svekkelse NO20042785L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200102725A ES2190373B1 (es) 2001-12-07 2001-12-07 Uso del acido 2-hidroxi- o 2-acetiloxi-4-trifluorometilbenzoico como agente para el tratamiento y prevencion del deterioro cognitivo ligero.
PCT/EP2002/013862 WO2003047562A1 (en) 2001-12-07 2002-12-06 Use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid derivatives as an agent for the treatment and prevention of mild cognitive impairment

Publications (1)

Publication Number Publication Date
NO20042785L true NO20042785L (no) 2004-07-01

Family

ID=8499682

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042785A NO20042785L (no) 2001-12-07 2004-07-01 Anvendelse av 2-hydroksy- eller 2-acetyloksy-4-trifluormetylbenzosyrederivater som et middel for behandlingen og forebyggingen av mild kognitiv svekkelse

Country Status (12)

Country Link
US (1) US20030162756A1 (es)
EP (1) EP1453499A1 (es)
JP (1) JP2005515993A (es)
KR (1) KR20050044742A (es)
AR (1) AR037728A1 (es)
AU (1) AU2002352228A1 (es)
BR (1) BR0214779A (es)
CA (1) CA2471794A1 (es)
ES (1) ES2190373B1 (es)
MX (1) MXPA04005450A (es)
NO (1) NO20042785L (es)
WO (1) WO2003047562A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060019938A1 (en) * 2003-12-31 2006-01-26 Beer Tomasz M Estrogen administration for treating male cognitive dysfunction or improving male cognitive function
WO2010134477A1 (ja) * 2009-05-18 2010-11-25 Jsr株式会社 感放射線性樹脂組成物及び化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096252A (en) * 1976-06-10 1978-06-20 J. Uriach & Cia S.A. 4-Trifluoromethylbenzoic acid derivatives as thromboembolic agents
ES2136581B1 (es) * 1998-05-27 2000-09-16 Uriach & Cia Sa J Uso de derivados del acido-2-hidroxi-4-trifluorometilbenzoico para la preparacion de medicamentos utiles para inhibir el factor de transcripcion nuclear nf-kb.
US6262042B1 (en) * 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties

Also Published As

Publication number Publication date
MXPA04005450A (es) 2005-04-19
AR037728A1 (es) 2004-12-01
ES2190373B1 (es) 2004-10-16
JP2005515993A (ja) 2005-06-02
US20030162756A1 (en) 2003-08-28
WO2003047562A1 (en) 2003-06-12
ES2190373A1 (es) 2003-07-16
CA2471794A1 (en) 2003-06-12
EP1453499A1 (en) 2004-09-08
AU2002352228A1 (en) 2003-06-17
KR20050044742A (ko) 2005-05-12
BR0214779A (pt) 2004-11-09

Similar Documents

Publication Publication Date Title
CL2004001165A1 (es) Compuestos derivados de anilina y difenilamino n-sustituidos; inhibidores de las enzimas pde4; composicion farmaceutica; y su uso para el tratamiento de desordenes cognitivos.
NO20033796D0 (no) Melkesyrebakterier som middel til å behandle og forebygge allergi
PT1144395E (pt) Derivados de 2-aminobenzoxazinona para o tratamento da obesidade
NO20014134D0 (no) Forbindelser med kondensert ring og anvendelse derav som legemidler
PT1143977E (pt) Derivados de 2-oxibenzoxazinona para o tratamento da obesidade
NO20001870D0 (no) Ny fremgangsmõte for behandling
DK1401806T3 (da) Benzoylsulfonamider og sulfonylbenzamidiner til anvendelse som antitumormidler
DK1546286T3 (da) Brandhæmmende middel og fremgangsmåde til fremstilling deraf
FI20010367A7 (fi) Menetelmä ja järjestely häiriön vaimentamiseksi
PT1282616E (pt) Derivados de hidroxifenil-piperidin-4-ilideno-metil-benzamida para o tratamentoda dor
FI20011403L (fi) Menetelmä ja koostumukset vatsan sairauksien hoitoon
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20002181D0 (no) Steriliseringsinnpakning, anvendelse derav og fremgangsmÕte for sterilisering
IS8004A (is) Aðferð við meðhöndlun á vægri vitsmunaskerðingu og til að fyrirbyggja eða tefja Alzheimers-sjúkdóminn
NO20054408D0 (no) 3(2-fenyl-oksazol-4-yl-metoksy)-cykloheksylmetoksyeddiksyrederivater og lignende forbindelser som PPAR-modulatorer for behandling av type 2 diabetes og arterosklerose
NO20042012L (no) Sammensetning og fremgangsmate for behandling av diabetes
ATE327752T1 (de) Aryl- (oder heteroaryl-) azolylcarbynolderivatve zur behandlung von harninkontinenz
NO20042904L (no) Anvendelse av norepinefrin-reopptakinhibitorer for behandling av kognitiv svikt
ATE443060T1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
NO20042785L (no) Anvendelse av 2-hydroksy- eller 2-acetyloksy-4-trifluormetylbenzosyrederivater som et middel for behandlingen og forebyggingen av mild kognitiv svekkelse
NO20033120D0 (no) 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
FI20040531A7 (fi) Insuliiniresistenttien tilojen hoitaminen ja diagnosointi
NO20013810D0 (no) Anvendelse av kolesterol senkende middel
PT1051172E (pt) Metodo para tratamento da dpco
DK1289945T3 (da) Anilindisulfidderivater til behandling af allergiske sygdomme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application